This inventor holds 1 USPTO granted patent. Top assignee: Biorex Kutato Es Fejleszto Rt. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Mihályné Kardos: Innovator in Pharmaceutical Research
Introduction
Mihályné Kardos is a notable inventor based in Veszprém, Hungary. He has made significant contributions to the field of pharmaceutical research, particularly in the treatment of insulin resistance. His innovative work has led to the development of a unique patent that addresses critical health issues related to diabetes.
Latest Patents
Mihályné Kardos holds a patent for N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance. This patent encompasses various aspects, including its stereoisomers and addition salts, as well as pharmaceutical compositions containing the compound. The methods outlined in the patent focus on treating pathological insulin resistance and associated conditions, such as diabetes-induced chronic complications, including retinopathy, neuropathy, and nephropathy.
Career Highlights
Kardos is affiliated with Biorex Kutató és Fejlesztő Rt, where he continues to advance his research in the pharmaceutical sector. His work is characterized by a commitment to improving health outcomes for individuals suffering from diabetes and related disorders.
Collaborations
Mihályné Kardos collaborates with esteemed colleagues, including Maria Kürthy and Katalin Bíró, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative solutions in the field of medicine.
Conclusion
Mihályné Kardos is a distinguished inventor whose work in pharmaceutical research has the potential to transform the treatment of insulin resistance and diabetes-related complications. His contributions are vital to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile